Mid-term report 2016 – Cancer prevention and precision medicine

In connection with Stiftelsen Kristian Gerhard Jebsen's Mid-term evaluation of The K.G. Jebsen Colorectal Cancer Research Centre, we have issued a Mid-term report.

Mid-term report 2016

Link to the report Mid-term_report 2016_oppslag

Latest publications

Thomsen et al., 2018. Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome. Br J Cancer 118(12):1609-1616 Mezheyeuski et al., 2018. Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer. Virchows Arch, 472(3): 395-405 Eide et al., 2018. Long non-coding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties. Int J Cancer, [Epub ahead of print] Guren et al., 2018. Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016. Clin Colorectal Cancer, [Epub ahead of print] Eilertsen IA et al., 2018. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer. Int J Cancer, [Epub ahead of print] All publications